Cargando…
HPMA-Based Copolymers Carrying STAT3 Inhibitor Cucurbitacin-D as Stimulus-Sensitive Nanomedicines for Oncotherapy
The study describes the synthesis, physicochemical properties, and biological evaluation of polymer therapeutics based on N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers intended for a tumor-targeted immuno-oncotherapy. Water-soluble linear and cholesterol-containing HPMA precursors were synthes...
Autores principales: | Tavares, Marina R., Hrabánková, Klára, Konefał, Rafał, Kaňa, Martin, Říhová, Blanka, Etrych, Tomáš, Šírová, Milada, Chytil, Petr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911143/ https://www.ncbi.nlm.nih.gov/pubmed/33525658 http://dx.doi.org/10.3390/pharmaceutics13020179 |
Ejemplares similares
-
HPMA Copolymer-Based Nanomedicines in Controlled Drug Delivery
por: Chytil, Petr, et al.
Publicado: (2021) -
Biocompatible glyconanomaterials based on HPMA-copolymer for specific targeting of galectin-3
por: Bojarová, P., et al.
Publicado: (2018) -
Intratumoral Distribution and pH-Dependent Drug Release of High Molecular Weight HPMA Copolymer Drug Conjugates Strongly Depend on Specific Tumor Substructure and Microenvironment
por: Noack, Anne-Kathrin, et al.
Publicado: (2020) -
Structure-to-Efficacy Relationship of HPMA-Based Nanomedicines: The Tumor Spheroid Penetration Study
por: Kudláčová, Júlia, et al.
Publicado: (2020) -
HPMA Copolymer Mebendazole Conjugate Allows Systemic Administration and Possesses Antitumour Activity In Vivo
por: Studenovský, Martin, et al.
Publicado: (2022)